234 related articles for article (PubMed ID: 36602800)
1. Large Variations in the Prices of Urologic Procedures at Academic Medical Centers 1 Year After Implementation of the Price Transparency Final Rule.
Gul ZG; Sharbaugh DR; Guercio CJ; Pelzman DL; Jones CA; Hacker EC; Anyaeche VI; Bowers L; Shah AM; Stencel MG; Yabes JG; Jacobs BL; Davies BJ
JAMA Netw Open; 2023 Jan; 6(1):e2249581. PubMed ID: 36602800
[TBL] [Abstract][Full Text] [Related]
2. Less Than One-third of Hospitals Provide Compliant Price Transparency Information for Total Joint Arthroplasty Procedures.
Burkhart RJ; Hecht CJ; Acuña AJ; Kamath AF
Clin Orthop Relat Res; 2022 Dec; 480(12):2316-2326. PubMed ID: 35901439
[TBL] [Abstract][Full Text] [Related]
3. Provision of Hospital Price Information After Increases in Financial Penalties for Failure to Comply With a US Federal Hospital Price Transparency Rule.
Kong E; Ji Y
JAMA Netw Open; 2023 Jun; 6(6):e2320694. PubMed ID: 37378982
[TBL] [Abstract][Full Text] [Related]
4. The Price-Quality Mismatch: Are Negotiated Prices for Total Joint Arthroplasty Associated With Hospital Quality in a Large California Health System?
Zhuang T; Shapiro LM; Baker LC; Kamal RN
Clin Orthop Relat Res; 2023 Jun; 481(6):1061-1068. PubMed ID: 36729581
[TBL] [Abstract][Full Text] [Related]
5. Health Care Price Transparency in Ophthalmology.
Berkowitz ST; Siktberg J; Hamdan SA; Triana AJ; Patel SN
JAMA Ophthalmol; 2021 Nov; 139(11):1210-1216. PubMed ID: 34617970
[TBL] [Abstract][Full Text] [Related]
6. Rural For-Profit Hospitals Are Associated With Higher Commercial Prices for 3 Common Urological Procedures.
Berger I; Spellman A; Golla V; Cerullo M; Zhang Y; Lipkin ME; Faerber GJ; Kaye DR; Scales CD
Urol Pract; 2023 Nov; 10(6):580-585. PubMed ID: 37647135
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated with Compliance to the Hospital Price Transparency Final Rule: a National Landscape Study.
Jiang JX; Polsky D; Littlejohn J; Wang Y; Zare H; Bai G
J Gen Intern Med; 2022 Nov; 37(14):3577-3584. PubMed ID: 34902095
[TBL] [Abstract][Full Text] [Related]
8. Association of Commercial-to-Medicare Relative Prices With Health System Financial Performance.
Blavin F; Kane N; Berenson R; Blanchfield B; Zuckerman S
JAMA Health Forum; 2023 Feb; 4(2):e225444. PubMed ID: 36763368
[TBL] [Abstract][Full Text] [Related]
9. Association Between Cancer Center Accreditation and Compliance With Price Disclosure of Common Oncologic Surgical Procedures.
Zhang Y; Cerullo M; Esposito A; Golla V
J Natl Compr Canc Netw; 2022 Nov; 20(11):1215-1222.e1. PubMed ID: 36351331
[TBL] [Abstract][Full Text] [Related]
10. Price transparency of prostate cancer care in the United States: An analysis of pricing and disclosure following the centers for medicare and medicaid mandate.
Brant A; Lewicki P; Rhodes S; Arenas-Gallo C; Strasser MO; Zhu A; Ponsky L; Shoag JE
Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):252-256. PubMed ID: 36717642
[TBL] [Abstract][Full Text] [Related]
11. Hospital-Administered Cancer Therapy Prices for Patients With Private Health Insurance.
Xiao R; Ross JS; Gross CP; Dusetzina SB; McWilliams JM; Sethi RKV; Rathi VK
JAMA Intern Med; 2022 Jun; 182(6):603-611. PubMed ID: 35435948
[TBL] [Abstract][Full Text] [Related]
12. Ongoing Challenges With Price Transparency in Hospital Charges for Hand Procedures.
Rhee BS; Kalliainen LK
J Hand Surg Am; 2023 Dec; 48(12):1263-1267. PubMed ID: 37676189
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Price Transparency via National Cancer Institute-Designated Cancer Centers' Chargemasters for Prostate Cancer Radiation Therapy.
Agarwal A; Dayal A; Kircher SM; Chen RC; Royce TJ
JAMA Oncol; 2020 Mar; 6(3):409-412. PubMed ID: 31944219
[TBL] [Abstract][Full Text] [Related]
14. Commercial Price Variation for Breast Reconstruction in the Era of Price Transparency.
Rochlin DH; Rizk NM; Matros E; Wagner TH; Sheckter CC
JAMA Surg; 2023 Feb; 158(2):152-160. PubMed ID: 36515928
[TBL] [Abstract][Full Text] [Related]
15. Large variations in hospital pricing for standard procedures revealed.
Shen C; Moss JL
BMC Res Notes; 2022 Apr; 15(1):129. PubMed ID: 35382890
[TBL] [Abstract][Full Text] [Related]
16. Uncovering the interhospital price variations for vasectomies in the United States.
Mortach S; Sellke N; Rhodes S; Sun HH; Tay K; Abou Ghayda R; Loeb A; Thirumavalavan N
Int J Impot Res; 2024 Feb; ():. PubMed ID: 38383856
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Hospital Pricing Information for Plastic Surgery Procedures Reveals Widespread Violation of the CMS Price Transparency Act.
Askinas C; Shih S; Puyana S; Chaffin AE; Jansen DA
Plast Reconstr Surg; 2023 Aug; 152(2):455-462. PubMed ID: 36790781
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Hospital Compliance With Federal Price Transparency Regulations and Variability of Negotiated Rates for Spinal Fusion.
Issa TZ; Lee Y; Mazmudar AS; Padovano R; Lambrechts MJ; Canseco JA; Hilibrand AS; Vaccaro AR; Kepler CK; Schroeder GD
J Am Acad Orthop Surg; 2023 Jul; 31(13):677-686. PubMed ID: 37015104
[TBL] [Abstract][Full Text] [Related]
19. Playing by the Rules? Tracking U.S. Hospitals' Responses to Federal Price Transparency Regulation.
Nikpay S; Carroll C; Golberstein E; Abraham JM
J Healthc Manag; 2024 Jan-Feb 01; 69(1):45-58. PubMed ID: 38175534
[TBL] [Abstract][Full Text] [Related]
20. Concordance of Disclosed Hospital Prices With Total Reimbursements for Hospital-Based Care Among Commercially Insured Patients in the US.
Horný M; Shafer PR; Dusetzina SB
JAMA Netw Open; 2021 Dec; 4(12):e2137390. PubMed ID: 34902037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]